• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期心力衰竭治疗的首要且最大障碍:护理人员短缺的影响。

The foremost and greatest barrier to end-stage heart failure treatment: the impact of caregiver shortage.

作者信息

Saito Shunsuke, Yoshioka Daisuke, Kawamura Takuji, Kawamura Ai, Misumi Yusuke, Akazawa Yasuhiro, Sera Fusako, Kubota Kaori, Yamauchi Takashi, Sakata Yasushi, Miyagawa Shigeru

机构信息

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.

出版信息

J Artif Organs. 2025 Jun;28(2):192-197. doi: 10.1007/s10047-024-01463-x. Epub 2024 Aug 7.

DOI:10.1007/s10047-024-01463-x
PMID:39110301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12078404/
Abstract

We examined the number of patients abandoning cardiac replacement therapy due to the inability to secure a designated caregiver. At Osaka University Hospital Heart Center, when we receive a consultation for a patient with severe heart failure from another hospital, a heart failure team makes a visit to the referring hospital as soon as possible. We retrospectively analyzed this hospital-visit database. We received 199 severe heart failure consultations from 2016-2023. Issues identified during hospital visits included age ≥ 65 years (8%), inability to confirm the patient's intention (8.5%), and explicit refusal of therapy (2.5%). Medical problems included multiple organ failure (18.1%), obesity (13.1%), diabetes (9.5%), malignancy (5.5%), chronic dialysis (1.0%), and other systemic diseases (12.6%). Adherence problems included poor medication compliance (3.5%), history of heavy drinking (2.5%), and smoking (2.0%). Social problems included inadequate family support in 16.1% of patients. Of the 199 patients, 95 (48.0%) proceeded to a heart transplant and LVAD indication review meeting at Osaka University Hospital. The remaining 104 patients (52.0%) did not proceed to the meeting. Reasons included improvement of heart failure with conservative treatment in 37 cases (35.6%), death before discussion in 21 cases (20.2%), medical contraindications in 18 cases (18.3%), lack of caregivers in 18 cases (18.3%; 9.5% of 199 cases), and patient refusal in 5 cases (4.8%). Approximately 10% of patients consulted at Osaka University Hospital Heart Center for severe heart failure abandoned cardiac replacement therapy due to the lack of caregivers.

摘要

我们调查了因无法确保有指定护理人员而放弃心脏替代治疗的患者数量。在大阪大学医院心脏中心,当我们收到来自其他医院的严重心力衰竭患者的会诊请求时,心力衰竭团队会尽快前往转诊医院。我们对这个医院访视数据库进行了回顾性分析。我们在2016年至2023年期间收到了199例严重心力衰竭会诊请求。医院访视期间发现的问题包括年龄≥65岁(8%)、无法确认患者意愿(8.5%)以及明确拒绝治疗(2.5%)。医疗问题包括多器官衰竭(18.1%)、肥胖(13.1%)、糖尿病(9.5%)、恶性肿瘤(5.5%)、慢性透析(1.0%)以及其他全身性疾病(12.6%)。依从性问题包括用药依从性差(3.5%)、酗酒史(2.5%)和吸烟(2.0%)。社会问题包括16.1%的患者家庭支持不足。在这199例患者中,95例(48.0%)前往大阪大学医院参加了心脏移植和左心室辅助装置适应症审查会议。其余104例患者(52.0%)未参加会议。原因包括37例(35.6%)经保守治疗心力衰竭得到改善、21例(20.2%)在讨论前死亡、18例(18.3%)存在医疗禁忌、18例(18.3%;占199例的9.5%)缺乏护理人员以及5例(4.8%)患者拒绝。在大阪大学医院心脏中心因严重心力衰竭接受会诊的患者中,约10%因缺乏护理人员而放弃了心脏替代治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b648/12078404/cf1879d0b379/10047_2024_1463_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b648/12078404/4b9d54816ec0/10047_2024_1463_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b648/12078404/c3e6b82e4959/10047_2024_1463_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b648/12078404/cf1879d0b379/10047_2024_1463_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b648/12078404/4b9d54816ec0/10047_2024_1463_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b648/12078404/c3e6b82e4959/10047_2024_1463_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b648/12078404/cf1879d0b379/10047_2024_1463_Fig3_HTML.jpg

相似文献

1
The foremost and greatest barrier to end-stage heart failure treatment: the impact of caregiver shortage.终末期心力衰竭治疗的首要且最大障碍:护理人员短缺的影响。
J Artif Organs. 2025 Jun;28(2):192-197. doi: 10.1007/s10047-024-01463-x. Epub 2024 Aug 7.
2
Left ventricular assist devices: an evidence-based analysis.左心室辅助装置:基于证据的分析
Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1.
3
Caregivers of Patients With Left Ventricular Assist Devices: Possible Impacts on Patients' Mortality and Interagency Registry for Mechanically Assisted Circulatory Support-Defined Morbidity Events.左心室辅助装置患者的护理人员:对患者死亡率及机械辅助循环支持定义的机构间注册处发病率事件的可能影响。
Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). doi: 10.1161/CIRCOUTCOMES.116.002879.
4
Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.作为移植桥梁的植入式左心室辅助装置的中期结果:日本单中心经验
J Cardiol. 2015 May;65(5):383-9. doi: 10.1016/j.jjcc.2014.06.007. Epub 2014 Jul 14.
5
Laparoscopic sleeve gastrectomy in patients with heart failure and left ventricular assist devices as a bridge to transplant.腹腔镜袖状胃切除术在心力衰竭和左心室辅助装置患者中的应用:作为移植桥接。
Surg Obes Relat Dis. 2018 Sep;14(9):1269-1273. doi: 10.1016/j.soard.2018.04.005. Epub 2018 Apr 19.
6
Decisional regret in left ventricular assist device patient-caregiver dyads.左心室辅助装置患者-照护者对决策的遗憾。
Heart Lung. 2019 Sep-Oct;48(5):400-404. doi: 10.1016/j.hrtlng.2019.05.003.
7
5-year results of a newly implemented mechanical circulatory support program for terminal heart failure patients in a Swiss non-cardiac transplant university hospital.瑞士非心脏移植大学医院终末期心力衰竭患者新实施的机械循环支持计划的 5 年结果。
J Cardiothorac Surg. 2021 Mar 31;16(1):64. doi: 10.1186/s13019-021-01447-5.
8
Left ventricular assist device destination therapy versus extended criteria cardiac transplant.左心室辅助装置作为终末期心衰治疗与标准外供心心脏移植的比较
Ann Thorac Surg. 2010 Apr;89(4):1205-9; discussion 1210. doi: 10.1016/j.athoracsur.2009.12.058.
9
Association of Patient Reported Outcomes With Caregiver Burden in Older Patients With Advanced Heart Failure: Insights From the SUSTAIN-IT Study.老年心力衰竭患者患者报告结局与照料者负担的相关性:来自 SUSTAIN-IT 研究的见解。
Circ Heart Fail. 2024 Jul;17(7):e011705. doi: 10.1161/CIRCHEARTFAILURE.124.011705. Epub 2024 Jun 24.
10
Outcomes Among Patients With Left Ventricular Assist Devices Receiving Maintenance Outpatient Hemodialysis: A Case Series.接受维持性门诊血液透析的左心室辅助装置患者的结局:病例系列。
Am J Kidney Dis. 2021 Feb;77(2):226-234. doi: 10.1053/j.ajkd.2020.04.018. Epub 2020 Jul 23.

引用本文的文献

1
Why Is Social Reintegration Support for Patients With Left Ventricular Assist Device Necessary?为什么对左心室辅助装置患者进行社会重新融入支持是必要的?
Circ Rep. 2025 Feb 21;7(3):147-153. doi: 10.1253/circrep.CR-25-0004. eCollection 2025 Mar 10.

本文引用的文献

1
Relationships among hemolysis indicators and neuron-specific-enolase in patients undergoing veno-arterial extracorporeal membrane oxygenation.接受静脉-动脉体外膜肺氧合治疗的患者溶血指标与神经元特异性烯醇化酶之间的关系。
J Artif Organs. 2025 Mar;28(1):43-49. doi: 10.1007/s10047-024-01454-y. Epub 2024 Jul 10.
2
Caregivers of patients with long-term implantable ventricular assist device: a republication of the article published in the Japanese Journal of Artificial Organs.长期植入式心室辅助装置患者的照料者:在日本人工器官杂志上发表的文章再版。
J Artif Organs. 2024 Sep;27(3):193-197. doi: 10.1007/s10047-024-01445-z. Epub 2024 May 23.
3
Short-Term Outcomes of Magnetically Levitated Left Ventricular Assist Device in Advanced Heart Failure - The Japanese Cohort.
日本磁悬浮左心室辅助装置治疗晚期心力衰竭的短期预后:一项日本队列研究。
Circ J. 2022 Nov 25;86(12):1961-1967. doi: 10.1253/circj.CJ-22-0332. Epub 2022 Oct 22.
4
The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report-2022; focus on transplant for restrictive heart disease.国际心肺移植协会国际胸器官移植登记处:2022年第39份成人心脏移植报告;聚焦限制性心脏病的移植
J Heart Lung Transplant. 2022 Oct;41(10):1366-1375. doi: 10.1016/j.healun.2022.07.018. Epub 2022 Jul 25.
5
JCS/JSCVS/JATS/JSVS 2021 Guideline on Implantable Left Ventricular Assist Device for Patients With Advanced Heart Failure.《日本循环学会/日本心血管外科学会/日本人工器官学会/日本血管外科学会2021年晚期心力衰竭患者植入式左心室辅助装置指南》
Circ J. 2022 May 25;86(6):1024-1058. doi: 10.1253/circj.CJ-21-0880. Epub 2022 Apr 5.
6
Changes in the Quality of Life of Patients with Left Ventricular Assist Device and their Caregivers in Japan: Retrospective Observational Study.日本左心室辅助装置患者及其护理人员的生活质量变化:回顾性观察研究。
Tohoku J Exp Med. 2022 May 25;257(1):45-55. doi: 10.1620/tjem.2022.J016. Epub 2022 Mar 31.
7
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.全磁悬浮左心室辅助装置 - 最终报告。
N Engl J Med. 2019 Apr 25;380(17):1618-1627. doi: 10.1056/NEJMoa1900486. Epub 2019 Mar 17.
8
Quality of life of family caregivers of patients with a left ventricular assist device in Japan.日本左心室辅助装置患者家庭照护者的生活质量
J Cardiol. 2018 Jan;71(1):81-87. doi: 10.1016/j.jjcc.2017.06.004. Epub 2017 Jul 31.
9
Assessment of patients' and caregivers' informational and decisional needs for left ventricular assist device placement: Implications for informed consent and shared decision-making.评估患者及护理人员对左心室辅助装置植入的信息需求和决策需求:对知情同意和共同决策的启示
J Heart Lung Transplant. 2015 Sep;34(9):1182-9. doi: 10.1016/j.healun.2015.03.026. Epub 2015 Mar 31.
10
Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association.机械循环支持的使用建议:设备策略与患者选择:美国心脏协会的科学声明
Circulation. 2012 Nov 27;126(22):2648-67. doi: 10.1161/CIR.0b013e3182769a54. Epub 2012 Oct 29.